Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Kiran Musunuru
Person

Kiran Musunuru

Tracked across 1 events · 11 articles · First seen Feb 11, 2026 · Last active Feb 11, 2026

Sentiment
60
Attention
6
Events
1
Relationships
3
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
6 60
Tech
Gene-Editing for High Cholesterol Breakthrough
Kiran Musunuru, a cardiologist at the University of Pennsylvania and co-founder of Verve PCSK9-inhibitor gene therapy, reported on the ANGPTL3 gene mutation and is a key figure in the development and tracking of gene-editing therapies for cholesterol.
Feb 11, 2026 · 11 articles
Relationships (3)
CRISPR Therapeutics ↔ Kiran Musunuru Unknown
Verve PCSK9-inhibitor gene therapy co-founder ↔ Kiran Musunuru Kiran Musunuru is a co-founder of Verve PCSK9-inhibitor gene therapy.
University of Pennsylvania cardiologist ↔ Kiran Musunuru Kiran Musunuru is a cardiologist at the University of Pennsylvania.
NEWSDESK
Track Kiran Musunuru live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.